Skip to main content
Top
Published in: Intensive Care Medicine 6/2016

01-06-2016 | WHAT’S NEW IN INTENSIVE CARE

Is this critically ill patient immunocompromised?

Authors: Frédéric Pène, Peter Pickkers, Richard S. Hotchkiss

Published in: Intensive Care Medicine | Issue 6/2016

Login to get access

Excerpt

In a very real sense, sepsis illustrates the multiple dimensions of the immune response of critically ill patients. On the one hand, sepsis can be viewed as the simple result of the interplay between a pathogen and the immune response to that pathogen. On the other hand, it is becoming clearer that this interplay is much more complex than it appeared. It often leads to major defects in immunity during recovery, conferring increased susceptibility to secondary infections and leading to worsened outcomes [1, 2]. …
Literature
1.
go back to reference Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150CrossRefPubMed Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150CrossRefPubMed
2.
go back to reference Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P (2013) Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med 187:1287–1293CrossRefPubMed Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P (2013) Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med 187:1287–1293CrossRefPubMed
3.
go back to reference Daviaud F, Grimaldi D, Dechartres A, Charpentier J, Geri G, Marin N, Chiche JD, Cariou A, Mira JP, Pene F (2015) Timing and causes of death in septic shock. Ann Intensive Care 5:58CrossRef Daviaud F, Grimaldi D, Dechartres A, Charpentier J, Geri G, Marin N, Chiche JD, Cariou A, Mira JP, Pene F (2015) Timing and causes of death in septic shock. Ann Intensive Care 5:58CrossRef
5.
go back to reference Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, Sharifi N, Janssen-Megens EM, Ter Huurne M, Mandoli A, van Schaik T, Ng A, Burden F, Downes K, Frontini M, Kumar V, Giamarellos-Bourboulis EJ, Ouwehand WH, van der Meer JW, Joosten LA, Wijmenga C, Martens JH, Xavier RJ, Logie C, Netea MG, Stunnenberg HG (2014) Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345:1251086CrossRefPubMedPubMedCentral Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, Sharifi N, Janssen-Megens EM, Ter Huurne M, Mandoli A, van Schaik T, Ng A, Burden F, Downes K, Frontini M, Kumar V, Giamarellos-Bourboulis EJ, Ouwehand WH, van der Meer JW, Joosten LA, Wijmenga C, Martens JH, Xavier RJ, Logie C, Netea MG, Stunnenberg HG (2014) Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345:1251086CrossRefPubMedPubMedCentral
6.
go back to reference Drewry AM, Fuller BM, Skrupky LP, Hotchkiss RS (2015) The presence of hypothermia within 24 hours of sepsis diagnosis predicts persistent lymphopenia. Crit Care Med 43:1165–1169CrossRefPubMed Drewry AM, Fuller BM, Skrupky LP, Hotchkiss RS (2015) The presence of hypothermia within 24 hours of sepsis diagnosis predicts persistent lymphopenia. Crit Care Med 43:1165–1169CrossRefPubMed
7.
go back to reference Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F, Milder M, Louis D, Chiche JD, Mira JP, Lantz O, Pene F (2014) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 40:192–201CrossRefPubMed Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F, Milder M, Louis D, Chiche JD, Mira JP, Lantz O, Pene F (2014) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 40:192–201CrossRefPubMed
8.
9.
go back to reference Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, Pachot A, Brooks TL, Deych E, Shannon WD, Green JM, Storch GA, Hotchkiss RS (2014) Reactivation of multiple viruses in patients with sepsis. PLoS One 9:e98819CrossRefPubMedPubMedCentral Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, Pachot A, Brooks TL, Deych E, Shannon WD, Green JM, Storch GA, Hotchkiss RS (2014) Reactivation of multiple viruses in patients with sepsis. PLoS One 9:e98819CrossRefPubMedPubMedCentral
10.
go back to reference Asehnoune K, Roquilly A, Abraham E (2012) Innate immune dysfunction in trauma patients: from pathophysiology to treatment. Anesthesiology 117:411–416CrossRefPubMed Asehnoune K, Roquilly A, Abraham E (2012) Innate immune dysfunction in trauma patients: from pathophysiology to treatment. Anesthesiology 117:411–416CrossRefPubMed
11.
go back to reference Manez R, Kusne S, Linden P, Gonzalez-Pinto I, Bonet H, Kramer D, Fung JJ, Starzl TE (1994) Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation 57:149–151CrossRefPubMedPubMedCentral Manez R, Kusne S, Linden P, Gonzalez-Pinto I, Bonet H, Kramer D, Fung JJ, Starzl TE (1994) Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation 57:149–151CrossRefPubMedPubMedCentral
12.
go back to reference Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D (2009) Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 37:2746–2752CrossRefPubMed Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D (2009) Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 37:2746–2752CrossRefPubMed
13.
go back to reference Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640–648CrossRefPubMed Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640–648CrossRefPubMed
14.
go back to reference Demaret J, Villars-Mechin A, Lepape A, Plassais J, Vallin H, Malcus C, Poitevin-Later F, Monneret G, Venet F (2014) Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients. Intensive Care Med 40:1089–1096CrossRefPubMed Demaret J, Villars-Mechin A, Lepape A, Plassais J, Vallin H, Malcus C, Poitevin-Later F, Monneret G, Venet F (2014) Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients. Intensive Care Med 40:1089–1096CrossRefPubMed
15.
go back to reference Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Vanhems P, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859–1866CrossRefPubMed Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Vanhems P, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859–1866CrossRefPubMed
16.
go back to reference Venet F, Foray AP, Villars-Mechin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G (2012) IL-7 restores lymphocyte functions in septic patients. J Immunol 189:5073–5081CrossRefPubMed Venet F, Foray AP, Villars-Mechin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G (2012) IL-7 restores lymphocyte functions in septic patients. J Immunol 189:5073–5081CrossRefPubMed
17.
go back to reference Wu J, Zhou L, Liu J, Ma G, Kou Q, He Z, Chen J, Ou-Yang B, Chen M, Li Y, Wu X, Gu B, Chen L, Zou Z, Qiang X, Chen Y, Lin A, Zhang G, Guan X (2013) The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit Care 17:R8CrossRefPubMedPubMedCentral Wu J, Zhou L, Liu J, Ma G, Kou Q, He Z, Chen J, Ou-Yang B, Chen M, Li Y, Wu X, Gu B, Chen L, Zou Z, Qiang X, Chen Y, Lin A, Zhang G, Guan X (2013) The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit Care 17:R8CrossRefPubMedPubMedCentral
18.
go back to reference Hotchkiss RS, Moldawer LL (2014) Parallels between cancer and infectious disease. N Engl J Med 371:380–383CrossRefPubMed Hotchkiss RS, Moldawer LL (2014) Parallels between cancer and infectious disease. N Engl J Med 371:380–383CrossRefPubMed
Metadata
Title
Is this critically ill patient immunocompromised?
Authors
Frédéric Pène
Peter Pickkers
Richard S. Hotchkiss
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 6/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-4161-y

Other articles of this Issue 6/2016

Intensive Care Medicine 6/2016 Go to the issue

Imaging in Intensive Care Medicine

Acute bioprosthetic mitral valve thrombosis